GSK5784283
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK5784283, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma [Phase 2]